| Identification | Back Directory | [Name]
JMV 176 | [CAS]
119068-32-5 | [Synonyms]
JMV 176
Boc-tyr(SO3)-nle-psi-(coch2)-gly-trp-nle-asp-phe-NH2
L-Phenylalaninamide, N-[5-[[2-[[(1,1-dimethylethoxy)carbonyl]amino]-1-oxo-3-[4-(sulfooxy)phenyl]propyl]amino]-1,4-dioxononyl]-L-tryptophyl-L-norleucyl-L-α-aspartyl-, [S-(R*,R*)]- (9CI) | [Molecular Formula]
C53H70N8O15S | [MDL Number]
MFCD00153537 | [MOL File]
119068-32-5.mol | [Molecular Weight]
1091.23 |
| Hazard Information | Back Directory | [Description]
Jmv 176 is a CCK agonist when first given, becomes cholecystokinin antagonist after 3-4 hours. | [Uses]
Jmv 176 is a CCK agonist when first given and becomes a cholecystokinin antagonist after 3-4 hours[1]. | [References]
[1] Gourch A, et al. A cholecystokinin agonist/antagonist according to dose and time of action: effect on food intake. Neuropeptides. 1990 Dec;17(4):187-91. DOI:10.1016/0143-4179(90)90034-v |
|
|